EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

IL-40 levels in treatment-naïve and methotrexate-treated rheumatoid arthritis patients

Hamdi Oğuzman iD, Mete Pekdiker iD

Turkish Journal of Medical Sciences · 20.06.2025 · 55 (3) · 658-665

DOI: 10.55730/1300-0144.6013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 20.06.2025. Verfasst von Hamdi Oğuzman und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biochemistry, Faculty of Medicine, Hatay Mustafa Kemal University, Hatay, Turkiye. Hauptthemen laut MEDLINE: Methotrexate, Arthritis, Rheumatoid, Antirheumatic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/aim: Rheumatoid arthritis (RA) is an autoimmune disease that is characterized by persistent inflammation and progressive damage to the joints. In this study, it was aimed to explore the role of interleukin (IL)-40, a newly discovered cytokine, in the pathogenesis of RA. We also aimed to investigate the relationship between IL-40 and other cytokines such as IL-4, transforming growth factor (TGF)-β1 and tumor necrosis factor (TNF)-α. Materials and methods: This single-center, cross-sectional study included 87 participants divided into three groups: healthy controls (n = 29), newly diagnosed RA patients (n = 29), and RA patients with remission under methotrexate (MTX) monotherapy (n = 29). Serum samples were collected and analyzed for IL-40, IL-4, TGF-β1 and TNF-α levels using ELISA. Disease activity score, presence of autoantibodies and other relevant clinical data were obtained from hospital electronic records.

Results

Elevated IL-40 levels were found in the newly diagnosed RA patients and in those treated with MTX compared to the control group (p < 0.001). Logistic regression analysis confirmed IL-40 as an independent predictor in the newly diagnosed (OR = 1.023, 95% CI: 1.010–1.035, p = 0.002) and RA MTX-treated patients (OR = 1.023, 95% CI: 1.011–1.036, p < 0.001). IL-40 levels remained unchanged in the newly diagnosed RA group compared to RA patients in the MTX-treated group. In the dual-seropositive patients, TGF-β1 was lower in the MTX-treated RA patients compared to the naive patients (p = 0.013) and in the dual-seronegative patients, TNF-α was decreased in the MTX-treated RA patients in comparison to naive patients (p = 0.043).

Conclusion

This study demonstrates that IL-40 levels are elevated in RA patients and highlights its potential role in RA. The fact that IL-40 levels did not change despite the antiinflammatory effects of MTX suggests that IL-40 is involved in immunological pathways that are less responsive to treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethotrexateArthritis, RheumatoidAntirheumatic AgentsHumansFemaleMaleCross-Sectional StudiesMiddle AgedAdultTumor Necrosis Factor-alphaTransforming Growth Factor beta1Aged

Stichwörter der Autor:innen

Interleukin-40cytokinesinterleukin-4methotrexatetransforming growth factor beta-1tumor necrosis factor-alpha

Substanzen

MethotrexateAntirheumatic AgentsTumor Necrosis Factor-alphaTransforming Growth Factor beta1

Autor:innen und Institutionen

  • Department of Medical Biochemistry, Faculty of Medicine, Hatay Mustafa Kemal University, Hatay, Turkiye.
  • Department of Rheumatology-Internal Medicine, Faculty of Medicine, Hatay Mustafa Kemal University, Hatay, Turkiye.

ORCID-Profile: Hamdi Oğuzman, Mete Pekdiker

Zitieren

APA

Oğuzman, H., & Pekdiker, M. (2025). IL-40 levels in treatment-naïve and methotrexate-treated rheumatoid arthritis patients. Turkish Journal of Medical Sciences, 55(3), 658-665. https://doi.org/10.55730/1300-0144.6013

Vancouver

Oğuzman H, Pekdiker M. IL-40 levels in treatment-naïve and methotrexate-treated rheumatoid arthritis patients. Turkish Journal of Medical Sciences. 2025;55(3):658-665. doi:10.55730/1300-0144.6013

BibTeX
@article{Ouzman2025,
  author = {Oğuzman, Hamdi and Pekdiker, Mete},
  title = {IL-40 levels in treatment-naïve and methotrexate-treated rheumatoid arthritis patients},
  journal = {Turkish Journal of Medical Sciences},
  year = {2025},
  volume = {55},
  number = {3},
  pages = {658--665},
  doi = {10.55730/1300-0144.6013}
}
Kostenlos starten →